(Q58402090)

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

The plasma and red cell vitamin B levels of chronic hemodialysis patients: a longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Longitudinal follow-up of chronic hemodialysis patients without vitamin supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Minimizing anemia in the chronic hemodialysis patient

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Do dialysis patients need extra folate?

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Water soluble vitamins in chronic hemodialysis patients and need for supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Deranged concentrations of water-soluble vitamins in the blood of undialyzed and dialyzed patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

The excretion of small doses of folic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Vitamin B6-deficiency and -substitution in chronic uremia (author's transl)

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Drugs, toxins and dietary amino acids affecting vitamin B12 or folic acid absorption or utilization

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Vitamin B6 deficiency in uremia

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Plasma pyridoxal-5'-phosphate levels and clinical correlations in chronic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Vitamin B6 deficiency in maintenance dialysis patients: metabolic effects of repletion

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Pyridoxal 5′-phosphate deficiency in uremic undialyzed, hemodialyzed, and non-uremic kidney transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Daily requirement for pyridoxine supplements in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Vitamin B6 requirements of patients on chronic peritoneal dialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Survival analysis of dialysis patients in Okinawa, Japan (1971-1990).

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Changing risk factor demographics in end-stage renal disease patients entering hemodialysis and the impact on long-term mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Diagnosis of cobalamin deficiency I: usefulness of serum methylmalonic acid and total homocysteine concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Homocysteinemia due to folate deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Accumulation of homocyst(e)ine in vitamin B-6 deficiency: a model for the study of cystathionine beta-synthase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Moderate homocysteinemia--a possible risk factor for arteriosclerotic cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Hyperhomocysteinemia: an independent risk factor for vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Neutrophils kill pulmonary endothelial cells by a hydrogen-peroxide-dependent pathway. An in vitro model of neutrophil-mediated lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Relationship of coronary risk factors to hemodialysis-associated ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: possible implications for prevention of vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021

Folic acid--an innocuous means to reduce plasma homocysteine.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-2276%2896%2990102-8

7 January 2021